Ethiopian Pharmaceutical Market, Forecast to 2020

Preference for Generic Prescription Drugs to Create New Market Dynamics, Demand for Anti-Infectives Rises

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This study offers an insight into the pharmaceutical industry of Ethiopia, where preference for generic, prescription drugs is growing. There is information on recent reforms introduced by the government (like tax benefits for in-country production, national strategy, and plan of action for pharmaceutical manufacturing development, growth and transformation plan, and so on), key participants in the market, population and disease statistics, and so on. The study also describes the opportunities and constraints in the market and revenue forecasts for the total market from 2011–2020. Primary research interviews with industry stakeholders and secondary research through in-house Frost & Sullivan database and news reports were undertaken.

Table of Contents

1. Executive Summary
Key Findings
Scope and Segmentation
Geographic coverage
Study period
Base year
Forecast period
Monetary unit
Conversion rate
Market Engineering Measurements
Market Stage
Market Revenue
Compound Annual Growth Rate
Customer Price Sensitivity
Degree of Technical Change
Number of Competitors
CEO’s Perspective
Key Companies to Watch
3 Big Predictions
2. Market Overview
Ethiopia
Infrastructure and Economic Situation
Healthcare Industry
Healthcare Infrastructure
Structure of Public Healthcare in Ethiopia
Per cent of Healthcare Facilities, Ethiopia, 2012
Total Number of Hospitals by Region, Ethiopia, 2012
Disease Profile
Healthcare Financing Indicators
Pharmaceutical Market—Background
Process of Procurement and Distribution
Essential Requirements for Drug Registration
Total Pharmaceutical Market—Segmentation
Increase in Generic Drugs’ Market Share
Per cent Sales Breakdown by Therapeutic Segment, Ethiopia, 2014
3. Competitive Playbook
New Market Opportunities
Total Pharmaceutical Market: Game-changing Strategies, Ethiopia, 2014
Merger, Acquisition, and Partnership Assessment
4. Drivers and Restraints
Key Market Drivers, Ethiopia, 2015-2020
Accelerating Ethiopian economic growth
Continuous requirement of anti-infective drugs
Escalating population
Increasing incidences of non-communicable diseases
Extension of healthcare coverage and improvements in infrastructure
Key Market Restraints, Ethiopia, 2015–2020
Shortage of FOREX with the National Bank
Deficiency of resources in medical institutions hampers the quality of workforce
Lengthy regulatory policies for the pharmaceutical industry
5. Forecast and Trends
Definitions
Revenue Forecast by Market Size
Revenue Forecast, Ethiopia, 2011–2020
Per Cent Revenue Forecast by Non-prescription, Generic, and Branded Drugs
Key Therapeutic Segment Growth Analysis, Ethiopia, 2014–2020
Growth Forecast by Key Therapeutic Segments, Ethiopia, 2014
Total Pharmaceutical Market: PESTLE Analysis, Ethiopia, 2014
6. Competitive Environment
Market Share—Prescription Drugs and Non-prescription Drugs
Market Share—Prescription Drugs and Non-prescription Drugs
Branded Drugs Segment: Per cent Revenue Breakdown, Ethiopia, 2014
7. Key Companies to Watch
Companies to Watch
Addis Pharmaceutical Factory PLC
Aurobindo Pharma Limited
Cadila Pharmaceutical
GlaxoSmithKline
Julphar
Novartis
8. The Last Word
Legal Disclaimer
9. Appendix
List of Companies in “Others”
Aurobindo Pharma
GSK
EPHARM
Bilium
Denk Pharma
Market Engineering Methodology

Infographic



List of Figures & Charts

1. Disease Indicators, Ethiopia, 2011 and 2013
2. Total Pharmaceutical Market: Key Market Drivers, Ethiopia, 2015-2020
3. Total Pharmaceutical Market: Key Market Restraints, Ethiopia, 2015–2020
4. Total Pharmaceutical Market: Market Engineering Measurements, Ethiopia, 2014
5. Total Pharmaceutical Market: Growth Forecast by Key Therapeutic Segments, Ethiopia, 2014


1. Total Pharmaceutical Market: Market Engineering Measurements, Ethiopia, 2014
2. Population Split by Gender, Ethiopia, 2014
3. Inflation at Consumer Prices, Ethiopia, 2010–2014 Annual Infrastructural Improvements, Ethiopia, 2011–2015
4. Per cent of Healthcare Facilities, Ethiopia, 2012
5. Total Number of Hospitals by Region, Ethiopia, 2012
6. Healthcare Expenditures, Ethiopia, 2010–2013
7. Healthcare Expenditures, Ethiopia, 2010–2013
8. Total Pharmaceutical Market: Procurement Process, Ethiopia, 2014
9. Total Pharmaceutical Market: Per cent Sales Breakdown by Therapeutic Segment, Ethiopia, 2014
10. Total Pharmaceutical Market: Revenue Forecast, Ethiopia, 2011–2020
11. Total Pharmaceutical Market: Per cent Revenue Forecast by Non-prescription, Generic and Branded Drugs, Ethiopia, 2011–2020
12. Total Pharmaceutical Market: Key Therapeutic Segment Growth Analysis, Ethiopia, 2014–2020
13. Total Pharmaceutical Market: Per cent Revenue Breakdown, Ethiopia, 2014
14. Generic Drugs Segment: Per cent Revenue Breakdown, Ethiopia, 2014
15. Branded Drugs Segment: Per cent Revenue Breakdown, Ethiopia, 2014
16. GDP Per Capita, Ethiopia, 2010–2014
17. Health Financing Sources, Ethiopia, 2013



Related Research

Release Date : 11-Oct-17

Region : Africa

Release Date : 11-Oct-17

Region : Africa

Release Date : 27-Sep-17

Region : Africa

Release Date : 22-Sep-17

Region : Africa

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.